All reports

KCE Reports 345C (2021) Each year, in Belgium, around 15,000 people have a pacemaker or defibrillator-type of heart device fitted. Some of these patients have their devices monitored remotely, but this service is not currently reimbursed. KCE was asked to assess the efficacy and the cost-effectiveness of this remote monitoring, and to examine the extent to which it would be desirable to reimburse the services of the health professionals concerned.

KCE Reports 300C (2018) The sequencing of the entire genome is a new form of genetic testing which, instead of targeting certain isolated genes, decodes all of an individual’s genes all at once (= his or her genome). This technology is advancing rapidly and its costs are decreasing, which suggests that it could soon displace conventional testing.